4.6 Article

Genetic risk variants for membranous nephropathy: extension of and association with other chronic kidney disease aetiologies

期刊

NEPHROLOGY DIALYSIS TRANSPLANTATION
卷 32, 期 2, 页码 325-332

出版社

OXFORD UNIV PRESS
DOI: 10.1093/ndt/gfw001

关键词

chronic kidney disease; genome-wide association study; membranous nephropathy

资金

  1. BMBF [031 5896 A]
  2. German Research Foundation [KO 3598/2-1, CRC/SFB 1140]
  3. David and Elaine Potter Charitable Foundation
  4. European Union [2013-305608]
  5. St Peter's Trust for Kidney, Bladder and Prostate Research
  6. Kids Kidney Research UK
  7. Medical Research Council (MRC) at the Centre for Integrated Genomic Medical Research, University of Manchester
  8. MRC [G0000934, MR/J010847/1]
  9. Wellcome Trust [068545/Z/02]
  10. Manchester Academic Health Science Centre [MAHSC 186/200]
  11. German Ministry of Education and Research (BMBF) [01ER0804]
  12. KfH Foundation for Preventive Medicine
  13. Medical Research Council [MR/J010847/1] Funding Source: researchfish
  14. MRC [MR/J010847/1] Funding Source: UKRI

向作者/读者索取更多资源

Background: Membranous nephropathy (MN) is a common cause of nephrotic syndrome in adults. Previous genome-wide association studies (GWAS) of 300 000 genotyped variants identifiedMN-associated loci at HLA-DQA1 and PLA2R1. Methods: We used a combined approach of genotype imputation, GWAS, human leucocyte antigen (HLA) imputation and extension to other aetiologies of chronic kidney disease (CKD) to investigate genetic MN risk variants more comprehensively. GWAS using 9 million high-quality imputed genotypes and classical HLA alleles were conducted for 323 MN Europeanancestry cases and 345 controls. Additionally, 4960 patients with different CKD aetiologies in the German Chronic Kidney Disease (GCKD) study were genotyped for risk variants at HLA-DQA1 and PLA2R1. Results: In GWAS, lead variants in known loci [rs9272729, HLA-DQA1, odds ratio (OR) = 7.3 per risk allele, P = 5.9 x 10-27 and rs17830558, PLA2R1, OR = 2.2, P = 1.9 x 10(-8)] were significantly associated with MN. No novel signals emerged in GWAS of X-chromosomal variants or in sexspecific analyses. Classical HLA alleles (DRB1* 0301-DQA1* 0501-DQB1* 0201 haplotype) were associated with MN but provided little additional information beyond rs9272729. Associations were replicated in 137 GCKD patients with MN (HLA-DQA1: P = 6.4 x 10(-24); PLA2R1: P = 5.0 x 10(-4)). MN risk increased steeply for patients with high-risk genotype combinations (OR > 79). While genetic variation in PLA2R1 exclusively associated with MN across 19 CKD aetiologies, the HLA-DQA1 risk allele was also associated with lupus nephritis (P = 2.8 x 10(-6)), type 1 diabetic nephropathy (P = 6.9 x 10(-5)) and focal segmental glomerulosclerosis (P = 5.1 x 10(-5)), but not with immunoglobulin A nephropathy. Conclusions: PLA2R1 and HLA-DQA1 are the predominant risk loci for MN detected by GWAS. While HLA-DQA1 risk variants show an association with other CKD aetiologies, PLA2R1 variants are specific to MN.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据